VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Mar 01, 2017 To Mar 31, 2017:


Bacillus anthracis (Anthrax)

  1. Golding H, Khurana S, Zaitseva M. What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection Cold Spring Harbor perspectives in biology 2017 [PMID: 28348035]
  2. Martin TL, Jee J, Kim E, Steiner HE, Cormet-Boyaka E, Boyaka PN. Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins Vaccine 2017 [PMID: 28343781]
  3. Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes Vaccine 2017 [PMID: 28342664]

Brucella (Brucellosis)

  1. Tang L, Liu J, Wang Y, Zhang H, Chen C. Evaluation of a hypervariable octameric oligonucleotide fingerprints assay for identification of and discrimination between wild-type and vaccine strains of Brucella melitensis American journal of veterinary research 78(4):495-499 2017 [PMID: 28345992]
  2. Lindahl-Rajala E, Hoffman T, Fretin D, Godfroid J, Sattorov N, Boqvist S, Lundkvist Å, Magnusson U. Detection and characterization of Brucella spp. in bovine milk in small-scale urban and peri-urban farming in Tajikistan PLoS neglected tropical diseases 11(3):e0005367 2017 [PMID: 28296882]
  3. Li MT, Sun GQ, Zhang WY, Jin Z. Model-Based Evaluation of Strategies to Control Brucellosis in China International journal of environmental research and public health 14(3) 2017 [PMID: 28287496]
  4. Hiriart Y, Rossi AH, Biedma ME, Errea AJ, Moreno G, Cayet D, Rinaldi J, Blancá B, Sirard JC, Goldbaum F, Berguer P, Rumbo M. Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella Protein science : a publication of the Protein Society 2017 [PMID: 28257593]
  5. Risso GS, Carabajal MV, Bruno LA, Ibañez AE, Coria LM, Pasquevich KA, Lee SJ, McSorley SJ, Briones G, Cassataro J. U-Omp19 from <i>Brucella abortus</i> Is a Useful Adjuvant for Vaccine Formulations against <i>Salmonella</i> Infection in Mice Frontiers in immunology 8:171 2017 [PMID: 28261222]

Burkholderia mallei (Glanders)

  1. Titball RW, Burtnick MN, Bancroft GJ, Brett P. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? Vaccine 2017 [PMID: 28336210]

Burkholderia pseudomallei (Melioidosis)

  1. Webb JR, Price EP, Currie BJ, Sarovich DS. Loss of methyltransferase function and increased efflux activity leads to doxycycline resistance in <i>Burkholderia pseudomallei</i> Antimicrobial agents and chemotherapy 2017 [PMID: 28348161]
  2. Lankelma JM, Wagemakers A, Birnie E, Haak BW, Trentelman JJ, Weehuizen TA, Ersöz J, Roelofs JJ, Hovius JW, Wiersinga WJ, Bins AD. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application Virulence :0 2017 [PMID: 28323523]
  3. Titball RW, Burtnick MN, Bancroft GJ, Brett P. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? Vaccine 2017 [PMID: 28336210]

Clostridium botulinum toxin (Botulism)

  1. Campbell AJ, Knight G, Walsh P, Bowen AC. Effective treatment of infant botulism on day 13 after symptom onset with human botulism antitoxin Journal of paediatrics and child health 2017 [PMID: 28306178]

Clostridium perfringens

  1. Gowane GR, Akram N, Prince LL, Prakash V, Kumar A. Genetic appraisal of serological response post vaccination against enterotoxaemia (ET) in Malpura and Avikalin sheep Tropical animal health and production 2017 [PMID: 28337572]
  2. Lillehoj HS, Jang SI, Panebra A, Lillehoj EP, Dupuis L, Arous JB, Lee SK, Oh ST. In Ovo Vaccination Using Eimeria Profilin and Clostridium perfringens NetB Proteins in Montanide IMS Adjuvant Increases Protective Immunity against Experimentally-induced Necrotic Enteritis Asian-Australasian journal of animal sciences 2017 [PMID: 28335090]
  3. Kang J, Gao J, Yao W, Kang L, Gao S, Yang H, Ji B, Li P, Liu J, Yao J, Xin W, Zhao B, Wang J. F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability Human vaccines & immunotherapeutics :0 2017 [PMID: 28304231]

Coxiella burnetii (Q fever)

  1. Lehner S, Lohan K, Dieckhoff HJ, Gerdes U. [Effects of vaccination against Q-fever in Lower Saxony dairy cattle farms] Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere 2017 [PMID: 28290594]
  2. Lord H, Fletcher-Lartey S, Weerasinghe G, Chandra M, Egana N, Schembri N, Conaty S. A Q fever cluster among workers at an abattoir in south-western Sydney, Australia, 2015 Western Pacific surveillance and response journal : WPSAR 7(4):21-27 2016 [PMID: 28246578]

Ebola virus

  1. Golding H, Khurana S, Zaitseva M. What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection Cold Spring Harbor perspectives in biology 2017 [PMID: 28348035]
  2. Schweneker M, Laimbacher AS, Zimmer G, Wagner S, Schraner EM, Wolferstätter M, Klingenberg M, Dirmeier U, Steigerwald R, Lauterbach H, Hochrein H, Chaplin P, Suter M, Hausmann J. Recombinant modified vaccinia virus Ankara generating Ebola virus-like particles Journal of virology 2017 [PMID: 28331098]
  3. Banadyga L, Marzi A. Closer than ever to an Ebola virus vaccine Expert review of vaccines 2017 [PMID: 28322076]
  4. Singh RK, Dhama K, Malik YS, Ramakrishnan MA, Karthik K, Khandia R, Tiwari R, Munjal A, Saminathan M, Sachan S, Desingu PA, Kattoor JJ, Iqbal HM, Joshi SK. Ebola virus - epidemiology, diagnosis and control: threat to humans, lessons learnt and preparedness plans - an update on its 40 year's journey The Veterinary quarterly :1-64 2017 [PMID: 28317453]
  5. Akkina R, Ellerbrok H, Hall W, Hasegawa H, Kawaguchi Y, Kleanthous H, McSweegan E, Mercer N, Romanowski V, Sawa H, Vahlne A. 2016 International meeting of the Global Virus Network Antiviral research 142:21-29 2017 [PMID: 28315708]
  6. Winslow RL, Milligan ID, Voysey M, Luhn K, Shukarev G, Douoguih M, Snape MD. Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year JAMA 317(10):1075-1077 2017 [PMID: 28291882]
  7. Rosales-Mendoza S, Nieto-Gómez R, Angulo C. A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus Frontiers in immunology 8:252 2017 [PMID: 28344580]
  8. Walsh PD, Kurup D, Hasselschwert DL, Wirblich C, Goetzmann JE, Schnell MJ. The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees? Scientific reports 7:43339 2017 [PMID: 28277549]
  9. Dayer JA, Siegrist CA, Huttner A. Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey PloS one 12(3):e0173148 2017 [PMID: 28273130]
  10. Seib K, Pollard AJ, de Wals P, Andrews RM, Zhou F, Hatchett RJ, Pickering LK, Orenstein WA. Policy making for vaccine use as a driver of vaccine innovation and development in the developed world Vaccine 35(10):1380-1389 2017 [PMID: 28253995]
  11. Lingemann M, Liu X, Surman S, Liang B, Herbert R, Hackenberg AD, Buchholz UJ, Collins PL, Munir S. Attenuated Human Parainfluenza Virus type 1 expressing Ebola Virus Glycoprotein GP Administered Intranasally is Immunogenic in African Green Monkeys Journal of virology 2017 [PMID: 28250127]
  12. Massaquoi MB, Kennedy SB. Ebola virus and malaria parasite positivity: a febrile illness quagmire The Lancet. Infectious diseases 2017 [PMID: 28258816]

Escherichia coli

  1. Jeiranikhameneh M, Razavi MR, Irani S, Siadat SD, Oloomi M. Designing novel construction for cell surface display of protein E on Escherichia coli using non-classical pathway based on Lpp-OmpA AMB Express 7(1):53 2017 [PMID: 28247289]
  2. Kumar A, Yogisharadhya R, Venkatesan G, Bhanuprakash V, Pandey AB, Shivachandra SB. Co-administration of recombinant major envelope proteins (rA27L and rH3L) of buffalopox virus provides enhanced immunogenicity and protective efficacy in animal models Antiviral research 141:174-178 2017 [PMID: 28259752]
  3. Han Y, Zhao B, Zhang M, Hong Y, Han H, Cao X, Lu K, Lin J, Fu Z. Biochemical properties and vaccine effect of recombinant TPx-3 from Schistosoma japonicum Parasitology research 116(4):1361-1372 2017 [PMID: 28285327]
  4. Rosales-Mendoza S, Sández-Robledo C, Bañuelos-Hernández B, Angulo C. Corn-based vaccines: current status and prospects Planta 2017 [PMID: 28349257]
  5. Kumar V, Yadav S, Soumya N, Kumar R, Babu NK, Singh S. Biochemical and inhibition studies of glutamine synthetase from Leishmania donovani Microbial pathogenesis 2017 [PMID: 28351708]
  6. Kesik-Brodacka M, Lipiec A, Kozak Ljunggren M, Jedlina L, Miedzinska K, Mikolajczak M, Plucienniczak A, Legocki AB, Wedrychowicz H. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae PLoS neglected tropical diseases 11(3):e0005451 2017 [PMID: 28333957]
  7. Hong ZW, Yang YC, Pan T, Tzeng HF, Fu HW. Differential effects of DEAE negative mode chromatography and gel-filtration chromatography on the charge status of Helicobacter pylori neutrophil-activating protein PloS one 12(3):e0173632 2017 [PMID: 28328957]
  8. Uthailak N, Mahamad P, Chittavanich P, Yanarojana S, Wijagkanalan W, Petre J, Panbangred W. Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli Molecular biotechnology 2017 [PMID: 28324209]
  9. Tsugo K, Nakamura S, Yamanaka H, Une Y. A study on the efficacy of the recombinant Yersinia adhesin A vaccine against yersiniosis in the early phase The Journal of veterinary medical science 2017 [PMID: 28320976]
  10. Won G, Lee JH. Potent immune responses induced by a salmonella ghost delivery system that expresses the recombinant stx2eb, fedf, and feda proteins of the escherichia coli-producing f18 and shiga toxin in a murine model and evaluation of its protective effect as a porcine vaccine candidate The Veterinary quarterly :1-27 2017 [PMID: 28317440]
  11. Landman WJ, Vervaet C, Remon JP, Huyge K, van Eck JH. Primary Newcastle disease vaccination of broilers: comparison of the antibody seroresponse and adverse vaccinal reaction after eye-nose drop or coarse spray application, and implication of the results for a previously developed coarse dry powder vaccine Avian pathology : journal of the W.V.P.A :1-38 2017 [PMID: 28303720]
  12. Arevalo-Villalobos JI, Govea-Alonso DO, Monreal-Escalante E, Zarazúa S, Rosales-Mendoza S. LTB-Syn: a recombinant immunogen for the development of plant-made vaccines against synucleinopathies Planta 2017 [PMID: 28315001]
  13. Kim BJ, Gong JR, Kim GN, Kim BR, Lee SY, Kook YH, Kim BJ. Recombinant Mycobacterium smegmatis with a pMyong2 vector expressing Human Immunodeficiency Virus Type I Gag can induce enhanced virus-specific immune responses Scientific reports 7:44776 2017 [PMID: 28300196]
  14. Alima Yanda AN, Nansseu JR, Mbassi Awa HD, Tatah SA, Seungue J, Eposse C, Koki PO. Burden and spectrum of bacterial infections among sickle cell disease children living in Cameroon BMC infectious diseases 17(1):211 2017 [PMID: 28298206]
  15. Bogado AL, Martins GF, Sasse JP, Guimarães JD Jr, Garcia JL. Molecular cloning, sequencing, and expression of Eimeria tenella HSP70 partial gene Genetics and molecular research : GMR 16(1) 2017 [PMID: 28301667]
  16. Novinrooz A, Zahraei Salehi T, Firouzi R, Arabshahi S, Derakhshandeh A. In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli PloS one 12(3):e0173761 2017 [PMID: 28296951]
  17. Hur J, Özgür A, He Y. Ontology-based literature mining of E. coli vaccine-associated gene interaction networks Journal of biomedical semantics 8(1):12 2017 [PMID: 28288685]
  18. Hao K, Chen XH, Qi XZ, Yu XB, Du EQ, Ling F, Zhu B, Wang GX. Protective immunity of grass carp induced by DNA vaccine encoding capsid protein gene (vp7) of grass carp reovirus using bacterial ghost as delivery vehicles Fish & shellfish immunology 2017 [PMID: 28300681]
  19. Greenhow TL, Hung YY, Herz A. Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines Pediatrics 2017 [PMID: 28283611]
  20. Roth R, van Zyl P, Tsekoa T, Stoychev S, Mamputha S, Buthelezi S, Crampton M. Co-expression of sulfhydryl oxidase and protein disulfide isomerase in Escherichia coli allows for production of soluble CRM<sub>197</sub> Journal of applied microbiology 2017 [PMID: 28276616]
  21. Hu W, Xiang JY, Kong P, Liu L, Xie Q, Xiang H. Expression and characterization of a single-chain variable fragment against human LOX-1 in Escherichia coli and Brevibacillus choshinensis Journal of microbiology and biotechnology 2017 [PMID: 28274103]
  22. Sun N, Zhang R, Duan G, Peng X, Wang C, Fan Q, Chen S, Xi Y. An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites BMC biotechnology 17(1):25 2017 [PMID: 28264682]
  23. MacDonald J, Miletic S, Gaildry T, Chin-Fatt A, Menassa R. Co-expression with the Type 3 Secretion Chaperone CesT from Enterohemorrhagic <i>E. coli</i> Increases Accumulation of Recombinant Tir in Plant Chloroplasts Frontiers in plant science 8:283 2017 [PMID: 28321227]
  24. Park JY, Park C, Chun HS, Byun JH, Cho SY, Lee DG. Establishment of Experimental Murine Peritonitis Model with Hog Gastric Mucin for Carbapenem-Resistant Gram-Negative Bacteria Infection & chemotherapy 2017 [PMID: 28271653]
  25. Wang D, Fan F, Li Z, Liu X, Song S, Wei S, He M, Lin Y, Li Z, Wei M, Yu H, Gu Y, Li S, Xia N. Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli Protein expression and purification 133:110-120 2017 [PMID: 28267627]
  26. de Oliveira NR, Jorge S, Gomes CK, Rizzi C, Pacce VD, Collares TF, Monte LG, Dellagostin OA. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice Veterinary microbiology 201:146-153 2017 [PMID: 28284602]
  27. Pina-Pedrero S, Olvera À, Bensaid A. The extended leader peptide of Haemophilus parasuis trimeric autotransporters conditions their protein expression in Escherichia coli Protein expression and purification 133:15-24 2017 [PMID: 28254554]
  28. Williams AH, Wheeler R, Thiriau C, Haouz A, Taha MK, Boneca IG. Bulgecin A: The Key to a Broad-Spectrum Inhibitor  That Targets Lytic Transglycosylases Antibiotics (Basel, Switzerland) 6(1) 2017 [PMID: 28241458]
  29. Dharmapalan D, Shet A, Yewale V, Sharland M. High Reported Rates of Antimicrobial Resistance in Indian Neonatal and Pediatric Blood Stream Infections Journal of the Pediatric Infectious Diseases Society 2017 [PMID: 28339675]
  30. Wang S, Zhang Z, Wang Y, Gadahi JA, Xu L, Yan R, Song X, Li X. <i>Toxoplasma gondii</i> Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis Frontiers in microbiology 8:168 2017 [PMID: 28243226]
  31. Uyar Y, Akşit A, Karaca S, Ceylan ŞS, Yürük M. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes] Mikrobiyoloji bulteni 51(1):41-51 2017 [PMID: 28283009]
  32. Mancha-Agresti P, Drumond MM, Carmo FL, Santos MM, Santos JS, Venanzi F, Chatel JM, Leclercq SY, Azevedo V. A New Broad Range Plasmid for DNA Delivery in Eukaryotic Cells Using Lactic Acid Bacteria: In Vitro and In Vivo Assays Molecular therapy. Methods & clinical development 4:83-91 2016 [PMID: 28344994]

Francisella tularensis (Tularemia)

  1. Morris BJ, Buse HY, Adcock NJ, Rice EW. A novel broth medium for enhanced growth of Francisella tularensis Letters in applied microbiology 2017 [PMID: 28255998]
  2. Aloni-Grinstein R, Schuster O, Yitzhaki S, Aftalion M, Maoz S, Steinberger-Levy I, Ber R. Isolation of <i>Francisella tularensis</i> and <i>Yersinia pestis</i> from Blood Cultures by Plasma Purification and Immunomagnetic Separation Accelerates Antibiotic Susceptibility Determination Frontiers in microbiology 8:312 2017 [PMID: 28293231]

Hantavirus

  1. Gowen BB, Hickerson BT. Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies Journal of microbiology (Seoul, Korea) 55(3):183-195 2017 [PMID: 28243938]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Crooks ET, Osawa K, Tong T, Grimley SL, Dai YD, Whalen RG, Kulp DW, Menis S, Schief WR, Binley JM. Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction Virology 505:193-209 2017 [PMID: 28279830]
  2. Shaikh N, Gupte A, Dharmshale S, Pokkali S, Thakar M, Upadhye VJ, Ordonez AA, Kinikar A, Gupte N, Mave V, Kagal A, Gupta A, Lalvani A, Paranjpe R, Bharadwaj R, Jain SK. Novel interferon-gamma assays for diagnosing tuberculosis in young children in India The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 21(4):412-419 2017 [PMID: 28284256]
  3. Kirby T. HIV vaccines: where are we now? The Lancet. Infectious diseases 17(4):372-373 2017 [PMID: 28346180]
  4. Reynolds N, Dearnley M, Hinton TM. Polymers in the Delivery of siRNA for the Treatment of Virus Infections Topics in current chemistry (Journal) 375(2):38 2017 [PMID: 28324594]
  5. Aguilera A, Trastoy R, Barreiro P, Costa JJ, de Mendoza C, Peña JM, Soriano V. Decline and changing profile of hepatitis delta among injection drug users in Spain Antiviral therapy 2017 [PMID: 28353446]
  6. Levy ME, Phillips G 2nd, Magnus M, Kuo I, Beauchamp G, Emel L, Hucks-Ortiz C, Hamilton EL, Wilton L, Chen I, Mannheimer S, Tieu HV, Scott H, Fields SD, Del Rio C, Shoptaw S, Mayer K. A Longitudinal Analysis of Treatment Optimism and HIV Acquisition and Transmission Risk Behaviors Among Black Men Who Have Sex with Men in HPTN 061 AIDS and behavior 2017 [PMID: 28352984]
  7. Jallow S, Madhi SA. Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children Expert review of vaccines 2017 [PMID: 28351187]
  8. Cao L, Diedrich JK, Kulp DW, Pauthner M, He L, Park SR, Sok D, Su CY, Delahunty CM, Menis S, Andrabi R, Guenaga J, Georgeson E, Kubitz M, Adachi Y, Burton DR, Schief WR, Yates Iii JR, Paulson JC. Global site-specific N-glycosylation analysis of HIV envelope glycoprotein Nature communications 8:14954 2017 [PMID: 28348411]
  9. Mocumbi S, Gafos M, Munguambe K, Goodall R, McCormack S. High HIV prevalence and incidence among women in Southern Mozambique: Evidence from the MDP microbicide feasibility study PloS one 12(3):e0173243 2017 [PMID: 28350843]
  10. Golding H, Khurana S, Zaitseva M. What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection Cold Spring Harbor perspectives in biology 2017 [PMID: 28348035]
  11. Martins MA, Watkins DI. What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive Cold Spring Harbor perspectives in biology 2017 [PMID: 28348034]
  12. Billeskov R, Wang Y, Solaymani-Mohammadi S, Frey B, Kulkarni S, Andersen P, Agger EM, Sui Y, Berzofsky JA. Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy Journal of immunology (Baltimore, Md. : 1950) 2017 [PMID: 28348274]
  13. Brekke K, Sommerfelt M, Ökvist M, Dyrhol-Riise AM, Kvale D. The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study BMC infectious diseases 17(1):228 2017 [PMID: 28340570]
  14. Scriven JE, Graham LM, Schutz C, Scriba TJ, Wilkinson KA, Wilkinson RJ, Boulware DR, Urban BC, Meintjes G, Lalloo DG. The CSF immune response in HIV-1-associated cryptococcal meningitis: macrophage activation, correlates of disease severity and effect of antiretroviral therapy Journal of acquired immune deficiency syndromes (1999) 2017 [PMID: 28346317]
  15. Descours B, Petitjean G, López-Zaragoza JL, Bruel T, Raffel R, Psomas C, Reynes J, Lacabaratz C, Levy Y, Schwartz O, Lelievre JD, Benkirane M. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses Nature 543(7646):564-567 2017 [PMID: 28297712]
  16. Nishimura Y, Gautam R, Chun TW, Sadjadpour R, Foulds KE, Shingai M, Klein F, Gazumyan A, Golijanin J, Donaldson M, Donau OK, Plishka RJ, Buckler-White A, Seaman MS, Lifson JD, Koup RA, Fauci AS, Nussenzweig MC, Martin MA. Early antibody therapy can induce long-lasting immunity to SHIV Nature 543(7646):559-563 2017 [PMID: 28289286]
  17. Kelly HA, Ngou J, Chikandiwa A, Sawadogo B, Gilham C, Omar T, Lompo O, Doutre S, Meda N, Weiss HA, Delany-Moretlwe S, Segondy M, Mayaud P. Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa PloS one 12(3):e0174117 2017 [PMID: 28333966]
  18. Lu W, Wan Y, Ma F, Johnson RP, Li Q. Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVΔnef live attenuated vaccine PloS one 12(3):e0173929 2017 [PMID: 28333940]
  19. Khan L, Kumar R, Thiruvengadam R, Parray HA, Makhdoomi MA, Kumar S, Aggarwal H, Mohata M, Hussain AW, Das R, Varadarajan R, Bhattacharya J, Vajpayee M, Murugavel KG, Solomon S, Sinha S, Luthra K. Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library Scientific reports 7:45163 2017 [PMID: 28332627]
  20. Shi J, Feng Y, Gao L, Feng D, Yao T, Shi S, Zhang Y, Liang X, Wang S. Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial Vaccine 2017 [PMID: 28343774]
  21. Richard J, Prévost J, von Bredow B, Ding S, Brassard N, Medjahed H, Coutu M, Melillo B, Bibollet-Ruche F, Hahn BH, Kaufmann DE, Smith AB 3rd, Sodroski J, Sauter D, Kirchhoff F, Gee K, Neil SJ, Evans DT, Finzi A. BST-2 Expression Modulates Small CD4 Mimetic Sensitization of HIV-1-infected cells to ADCC Journal of virology 2017 [PMID: 28331088]
  22. Moustafa A, Xie C, Kirkness E, Biggs W, Wong E, Turpaz Y, Bloom K, Delwart E, Nelson KE, Venter JC, Telenti A. The blood DNA virome in 8,000 humans PLoS pathogens 13(3):e1006292 2017 [PMID: 28328962]
  23. Castelli F, Sulis G. Migration and infectious diseases Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2017 [PMID: 28336382]
  24. Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM. HIV-specific ADCC - new technologies to study ADCC and importance for the HIV vaccine field Current HIV research 2017 [PMID: 28322167]
  25. Luo M, Samandi LZ, Wang Z, Chen ZJ, Gao J. Synthetic nanovaccines for immunotherapy Journal of controlled release : official journal of the Controlled Release Society 2017 [PMID: 28336379]
  26. Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP. Effectiveness of UNAIDS targets and HIV vaccination across 127 countries Proceedings of the National Academy of Sciences of the United States of America 2017 [PMID: 28320938]
  27. Gagneux-Brunon A, Rochereau N, Botelho-Nevers E, Lucht F, Pozzetto B, Paul S, Bourlet T. Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies AIDS (London, England) 2017 [PMID: 28323750]
  28. Krammer F. Strategies to induce broadly protective antibody responses to viral glycoproteins Expert review of vaccines :1-11 2017 [PMID: 28277797]
  29. Haynes BF, Burton DR. Developing an HIV vaccine Science (New York, N.Y.) 355(6330):1129-1130 2017 [PMID: 28302812]
  30. Van Regenmortel MH. Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV Vaccine 2017 [PMID: 28320589]
  31. Akkina R, Ellerbrok H, Hall W, Hasegawa H, Kawaguchi Y, Kleanthous H, McSweegan E, Mercer N, Romanowski V, Sawa H, Vahlne A. 2016 International meeting of the Global Virus Network Antiviral research 142:21-29 2017 [PMID: 28315708]
  32. Li Q, Liu Q, Huang W, Song A, Zhao C, Wu J, Wang Y. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines Human vaccines & immunotherapeutics :1-8 2017 [PMID: 28301274]
  33. Curreli F, Kwon YD, Belov DS, Ramesh RR, Kurkin AV, Altieri A, Kwong PD, Debnath AK. Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120 Journal of medicinal chemistry 2017 [PMID: 28266845]
  34. Nayakwadi Singer M, Heath C, Muinde J, Gildengorin V, Mutuku FM, Vu D, Mukoko D, King CL, Malhotra IJ, King CH, LaBeaud AD. Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood Pediatrics 2017 [PMID: 28302673]
  35. Duque J, Gaga S, Clark D, Muller M, Kuwane B, Cohen C, Walaza S, Tempia S, Ramatoboe P, Furumele T, Widdowson MA, McMorrow ML, Cohen AL. Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals PloS one 12(3):e0173983 2017 [PMID: 28301593]
  36. Kim BJ, Gong JR, Kim GN, Kim BR, Lee SY, Kook YH, Kim BJ. Recombinant Mycobacterium smegmatis with a pMyong2 vector expressing Human Immunodeficiency Virus Type I Gag can induce enhanced virus-specific immune responses Scientific reports 7:44776 2017 [PMID: 28300196]
  37. Huang X, Zhu Q, Huang X, Yang L, Song Y, Zhu P, Zhou P. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses Vaccine 2017 [PMID: 28318765]
  38. Fan Q, Nelson CS, Bialas KM, Chiuppesi F, Amos J, Gurley TC, Marshall DJ, Eudailey J, Heimsath H, Himes J, Deshpande A, Walter MR, Wussow F, Diamond DJ, Barry PA, Moody MA, Kaur A, Permar SR. Plasmablast Response to Primary Rhesus Cytomegalovirus Infection in a Monkey Model of Congenital CMV Transmission Clinical and vaccine immunology : CVI 2017 [PMID: 28298291]
  39. de Bree GJ, Wheatley AK, Lynch RM, Prabhakaran M, Grijsen ML, Prins JM, Schmidt SD, Koup RA, Mascola JR, McDermott AB. Longitudinal dynamics of the HIV-specific B cell response during intermittent treatment of primary HIV infection PloS one 12(3):e0173577 2017 [PMID: 28296911]
  40. Alam SM, Aussedat B, Vohra Y, Ryan Meyerhoff R, Cale EM, Walkowicz WE, Radakovich NA, Anasti K, Armand L, Parks R, Sutherland L, Scearce R, Joyce MG, Pancera M, Druz A, Georgiev IS, Von Holle T, Eaton A, Fox C, Reed SG, Louder M, Bailer RT, Morris L, Abdool-Karim SS, Cohen M, Liao HX, Montefiori DC, Park PK, Fernández-Tejada A, Wiehe K, Santra S, Kepler TB, Saunders KO, Sodroski J, Kwong PD, Mascola JR, Bonsignori M, Moody MA, Danishefsky S, Haynes BF. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide Science translational medicine 9(381) 2017 [PMID: 28298421]
  41. Bonsignori M, Kreider EF, Fera D, Meyerhoff RR, Bradley T, Wiehe K, Alam SM, Aussedat B, Walkowicz WE, Hwang KK, Saunders KO, Zhang R, Gladden MA, Monroe A, Kumar A, Xia SM, Cooper M, Louder MK, McKee K, Bailer RT, Pier BW, Jette CA, Kelsoe G, Williams WB, Morris L, Kappes J, Wagh K, Kamanga G, Cohen MS, Hraber PT, Montefiori DC, Trama A, Liao HX, Kepler TB, Moody MA, Gao F, Danishefsky SJ, Mascola JR, Shaw GM, Hahn BH, Harrison SC, Korber BT, Haynes BF. Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies Science translational medicine 9(381) 2017 [PMID: 28298420]
  42. Wang Y, Kong D, Xu W, Li F, Liang S, Feng Y, Zhang F, Shao Y, Ma L. Identification of a Novel HIV Type 1 CRF01_AE/B'/C Recombinant Isolate in Sichuan, China AIDS research and human retroviruses 2017 [PMID: 28287833]
  43. Cillóniz C, Torres A, Manzardo C, Gabarrús A, Ambrosioni J, Salazar A, García F, Ceccato A, Mensa J, Puig de la Bella Casa J, Moreno A, Miró JM. Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study Chest 2017 [PMID: 28302496]
  44. Sadlier C, O'Rourke A, Carr A, Bergin C. Seroepidemiology of hepatitis A, hepatitis B and varicella virus in people living with HIV in Ireland Journal of infection and public health 2017 [PMID: 28302512]
  45. Hustache S, Moyroud L, Goirand L, Epaulard O. Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2017 [PMID: 28285330]
  46. Mikheecheva NE, Zaychikova MV, Melerzanov AV, Danilenko VN. A nonsynonymous SNP catalog of Mycobacterium tuberculosis virulence genes and its use for detecting new potentially virulent sublineages Genome biology and evolution 2017 [PMID: 28338924]
  47. Rujas E, Insausti S, García-Porras M, Sánchez-Eugenia R, Tsumoto K, Nieva JL, Caaveiro JM. Functional Contacts between MPER and the Anti-HIV-1 Broadly Neutralizing Antibody 4E10 Extend into the Core of the Membrane Journal of molecular biology 2017 [PMID: 28300601]
  48. Bunyasi EW, Schmidt BM, Abdullahi LH, Mulenga H, Tameris M, Luabeya A, Shenje J, Scriba T, Geldenhuys H, Wood R, Hatherill M. Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol BMJ open 7(3):e014609 2017 [PMID: 28283492]
  49. Wagner R. Effective HIV vaccine: narrow path to broadly neutralizing antibodies? Current opinion in HIV and AIDS 2017 [PMID: 28257303]
  50. Hsu DC, O'Connell RJ. Progress in HIV vaccine development Human vaccines & immunotherapeutics :1-13 2017 [PMID: 28281871]
  51. Teeraananchai S, Bunupuradah T, Puthanakit T, Kerr SJ, Ruxrungtham K, Chaivooth S, Bhakeecheep S, Law MG, Chokephaibulkit K. First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand Journal of acquired immune deficiency syndromes (1999) 2017 [PMID: 28291052]
  52. Kahn J, Xu J, Kapogiannis BG, Sleasman JW. Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay Journal of acquired immune deficiency syndromes (1999) 2017 [PMID: 28291048]
  53. Ahmed S, Shrivastava T, Kumar N, Ozorowski G, Ward AB, Chakrabarti BK. Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein The Journal of biological chemistry 2017 [PMID: 28283570]
  54. Mühle M, Lehmann M, Hoffmann K, Stern D, Kroniger T, Luttmann W, Denner J. Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1 PloS one 12(3):e0173454 2017 [PMID: 28282446]
  55. Chapman R, Jongwe TI, Douglass N, Chege G, Williamson AL. Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice PloS one 12(3):e0173352 2017 [PMID: 28278263]
  56. Bayley J, Mesher D, Nadarzynski T, Hughes G, Soldan K. Attendance of MSM at Genitourinary Medicine services in England: implications for selective HPV vaccination programme (a short communication) Sexually transmitted infections 2017 [PMID: 28280237]
  57. Kim S, Huang Y. Combining biomarkers for classification with covariate adjustment Statistics in medicine 2017 [PMID: 28276080]
  58. Xu H, Andersson AM, Ragonnaud E, Boilesen D, Tolver A, Jensen BA, Blanchard JL, Nicosia A, Folgori A, Colloca S, Cortese R, Thomsen AR, Christensen JP, Veazey RS, Holst PJ. Mucosal vaccination with heterologous viral vectored vaccine targeting subdominant SIV accessory antigens strongly inhibits early viral replication EBioMedicine 2017 [PMID: 28302457]
  59. Chuang GY, Geng H, Pancera M, Xu K, Cheng C, Acharya P, Chambers M, Druz A, Tsybovsky Y, Wanninger TG, Yang Y, Doria-Rose NA, Georgiev IS, Gorman J, Joyce MG, O'Dell S, Zhou T, McDermott AB, Mascola JR, Kwong PD. Structure-Based Design of a Soluble Prefusion-Closed HIV-1-Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity Journal of virology 2017 [PMID: 28275193]
  60. Qureshi H, Bhattacharya J. Dual Immunity Concomitantly Suppresses HIV-1 Progression Trends in microbiology 2017 [PMID: 28284876]
  61. Ji Z, Xie Z, Zhang Z, Gong T, Sun X. Engineering intravaginal vaccines to overcome mucosal and epithelial barriers Biomaterials 128:8-18 2017 [PMID: 28285195]
  62. Cardinaud S, Urrutia A, Rouers A, Coulon PG, Kervevan J, Richetta C, Bet A, Maze EA, Larsen M, Iglesias MC, Appay V, Graff-Dubois S, Moris A. Triggering of TLR-3, -4, NOD2 and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells European journal of immunology 2017 [PMID: 28266028]
  63. Zulfiqar HF, Javed A, Sumbal, Afroze B, Ali Q, Akbar K, Nadeem T, Rana MA, Nazar ZA, Nasir IA, Husnain T. HIV Diagnosis and Treatment through Advanced Technologies Frontiers in public health 5:32 2017 [PMID: 28326304]
  64. Seib K, Pollard AJ, de Wals P, Andrews RM, Zhou F, Hatchett RJ, Pickering LK, Orenstein WA. Policy making for vaccine use as a driver of vaccine innovation and development in the developed world Vaccine 35(10):1380-1389 2017 [PMID: 28253995]
  65. Seth L, Bingham Ferlez KM, Kaba SA, Musser DM, Emadi S, Matyas GR, Beck Z, Alving CR, Burkhard P, Lanar DE. Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants Vaccine 2017 [PMID: 28274638]
  66. Lau YF, Tang LH, Chien Lye D, Ooi EE, Leo YS. Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore Human vaccines & immunotherapeutics 13(3):551-560 2017 [PMID: 28277090]
  67. Gruell H, Klein F. Progress in HIV-1 antibody research using humanized mice Current opinion in HIV and AIDS 2017 [PMID: 28257302]
  68. McElrath MJ. Adjuvants: tailoring humoral immune responses Current opinion in HIV and AIDS 2017 [PMID: 28257301]
  69. Peterhoff D, Wagner R. Guiding the long way to broad HIV neutralization Current opinion in HIV and AIDS 2017 [PMID: 28257300]
  70. Venkatesan A, Febin Prabhu Dass J. Deciphering molecular properties and docking studies of hepatitis C and non-hepatitis C antiviral inhibitors - A computational approach Life sciences 174:8-14 2017 [PMID: 28259653]
  71. Juga AJ, Hens N, Osman N, Aerts M. A flexible method to model HIV serodiscordance among couples in Mozambique PloS one 12(3):e0172959 2017 [PMID: 28253283]
  72. Giersing BK, Vekemans J, Nava S, Kaslow DC, Moorthy V. Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016 Vaccine 2017 [PMID: 28262332]
  73. Kessels JA, Recuenco S, Navarro-Vela AM, Deray R, Vigilato M, Ertl H, Durrheim D, Rees H, Nel LH, Abela-Ridder B, Briggs D. Pre-exposure rabies prophylaxis: a systematic review Bulletin of the World Health Organization 95(3):210-219C 2017 [PMID: 28250534]
  74. Detoc M, Gagneux-Brunon A, Lucht F, Botelho-Nevers E. Barriers and motivations to volunteers' participation in preventive vaccine trials: a systematic review Expert review of vaccines :1-11 2017 [PMID: 28277098]
  75. Jessop AB, Hom JK, Burke M. Variation in the Viral Hepatitis and HIV Policies and Practices of Methadone Maintenance Programs Journal of addiction medicine 2017 [PMID: 28252455]
  76. Campos-Outcalt D. Practice Alert: ACIP vaccine update, 2017 The Journal of family practice 66(3):166-169 2017 [PMID: 28249054]
  77. Brito MO, Khosla S, Pananookooln S, Fleming PJ, Lerebours L, Donastorg Y, Bailey RC. Sexual Pleasure and Function, Coital Trauma, and Sex Behaviors After Voluntary Medical Male Circumcision Among Men in the Dominican Republic The journal of sexual medicine 2017 [PMID: 28258953]
  78. Liu Y, Pan J, Cai Y, Grigorieff N, Harrison SC, Chen B. Conformational states of a soluble, uncleaved HIV-1 envelope trimer Journal of virology 2017 [PMID: 28250125]
  79. Smith SA, Derdeyn CA. New connections: Cell to cell HIV-1 transmission, resistance to broadly neutralizing antibodies, and an envelope sorting motif Journal of virology 2017 [PMID: 28250119]
  80. Aikins ME, Bazzill J, Moon JJ. Vaccine nanoparticles for protection against HIV infection Nanomedicine (London, England) 12(6):673-682 2017 [PMID: 28244816]
  81. Saunders KO, Nicely NI, Wiehe K, Bonsignori M, Meyerhoff RR, Parks R, Walkowicz WE, Aussedat B, Wu NR, Cai F, Vohra Y, Park PK, Eaton A, Go EP, Sutherland LL, Scearce RM, Barouch DH, Zhang R, Von Holle T, Overman RG, Anasti K, Sanders RW, Moody MA, Kepler TB, Korber B, Desaire H, Santra S, Letvin NL, Nabel GJ, Montefiori DC, Tomaras GD, Liao HX, Alam SM, Danishefsky SJ, Haynes BF. Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates Cell reports 18(9):2175-2188 2017 [PMID: 28249163]
  82. Delory T, Ngo-Giang-Huong N, Rangdaeng S, Chotivanich N, Limtrakul A, Putiyanun C, Suriyachai P, Matanasarawut W, Jarupanich T, Liampongsabuddhi P, Heard I, Jourdain G, Lallemant M, Le Coeur S. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand The Journal of infection 2017 [PMID: 28254419]
  83. Morris CD, Azadnia P, de Val N, Vora N, Honda A, Giang E, Saye-Francisco K, Cheng Y, Lin X, Mann CJ, Tang J, Sok D, Burton DR, Law M, Ward AB, He L, Zhu J. Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers mBio 8(1) 2017 [PMID: 28246356]
  84. Bekker LG, Gray GE. Hope for HIV control in southern Africa: The continued quest for a vaccine PLoS medicine 14(2):e1002241 2017 [PMID: 28245236]
  85. Isaacs-Long Y, Myer L, Zar HJ. Trends in admissions, morbidity and outcomes at Red Cross War Memorial Children's Hospital, Cape Town, 2004 - 2013 South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 107(3):219-226 2017 [PMID: 28281427]
  86. Joseph S, Quinn K, Greenwood A, Cope AV, McKay PF, Hayes PJ, Kopycinski JT, Gilmour J, Miller AN, Geldmacher C, Nadai Y, Ahmed MI, Montefiori DC, Dally L, Bouliotis G, Lewis DJ, Tatoud R, Wagner R, Esteban M, Shattock RJ, McCormack S, Weber J. A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes Frontiers in immunology 8:149 2017 [PMID: 28275375]
  87. Abdoli A, Radmehr N, Bolhassani A, Eidi A, Mehrbod P, Motevalli F, Kianmehr Z, Chiani M, Mahdavi M, Yazdani S, Ardestani MS, Kandi MR, Aghasadeghi MR. Conjugated anionic PEG-citrate G2 dendrimer with multi-epitopic HIV-1 vaccine candidate enhance the cellular immune responses in mice Artificial cells, nanomedicine, and biotechnology :1-7 2017 [PMID: 28278580]
  88. Moukambi F, Rodrigues V, Fortier Y, Rabezanahary H, Borde C, Krust B, Andreani G, Silvestre R, Petrovas C, Laforge M, Estaquier J. CD4 T Follicular Helper Cells and HIV Infection: Friends or Enemies? Frontiers in immunology 8:135 2017 [PMID: 28265271]
  89. Warshaw MG, Siberry GK, Williams P, Decker MD, Jean-Philippe P, Lujan-Zilbermann J. Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and Youth Journal of the Pediatric Infectious Diseases Society 2017 [PMID: 28339668]
  90. Yang Y, Zhu Q, Sun W, Guo J, Ning X, Li Q, Guo Y, Li J, Kou Z, Zhou Y. A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection Human vaccines & immunotherapeutics :1-9 2017 [PMID: 28281860]
  91. Catherine FX, Piroth L. Hepatitis B virus vaccination in HIV-infected people: a review Human vaccines & immunotherapeutics :1-10 2017 [PMID: 28267387]
  92. Roberts JR, Siekas LL, Kaz AM. Anal intraepithelial neoplasia: A review of diagnosis and management World journal of gastrointestinal oncology 9(2):50-61 2017 [PMID: 28255426]
  93. Rijkers G. Cutting the Stone: Health Defined in the Era of Value-based Care Cureus 9(2):e1023 2017 [PMID: 28348941]
  94. Khan MA. An Update on the Genetic Polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting) Current rheumatology reports 19(2):9 2017 [PMID: 28247302]
  95. Mammas IN, Theodoridou M, Kramvis A, Thiagarajan P, Gardner S, Papaioannou G, Melidou A, Koutsaki M, Kostagianni G, Achtsidis V, Koutsaftiki C, Calachanis M, Zaravinos A, Greenough A, Spandidos DA. Paediatric Virology: A rapidly increasing educational challenge Experimental and therapeutic medicine 13(2):364-377 2017 [PMID: 28352303]
  96. Keeshin SW, Feinberg J. Text Message Reminder-Recall to Increase HPV Immunization in Young HIV-1-Infected Patients Journal of the International Association of Providers of AIDS Care 16(2):110-113 2017 [PMID: 28325131]
  97. Lawrence D, Kuo L, Church E, Poon B, Smiley S, Sanders-Beer B, Dawson L, Salzwedel K. Highlights from the Third Biennial Strategies for an HIV Cure Meeting: 14-16 November 2016, Bethesda, MD, USA Journal of virus eradication 3(1):69-76 2017 [PMID: 28275462]
  98. Lowe HI, Toyang NJ, McLaughlin W. Potential of Cannabidiol for the Treatment of Viral Hepatitis Pharmacognosy research 9(1):116-118 2017 [PMID: 28250664]
  99. Barefoot KN, Warren JC, Smalley KB. Women's health care: the experiences and behaviors of rural and urban lesbians in the USA Rural and remote health 17(1):3875 2017 [PMID: 28248528]
  100. Raduege TJ. Benefits and Services Issue brief (Health Policy Tracking Service) 2016:1-56 2016 [PMID: 28248072]
  101. Odekunle FF, Odekunle RO. The impact of the US president's emergency plan for AIDS relief (PEPFAR) HIV and AIDS program on the Nigerian health system The Pan African medical journal 25:143 2016 [PMID: 28292105]
  102. Chin LJ, Berenson JA, Klitzman RL. Typologies of Altruistic and Financial Motivations for Research Participation Journal of empirical research on human research ethics : JERHRE 11(4):299-310 2016 [PMID: 28251864]
  103. Bhattacharya SD, Arya BK. Immediate access to antiretroviral therapy is important in children living with HIV Journal of family medicine and primary care 5(4):860-862 2016 [PMID: 28349006]
  104. Sarac F, Uslan V, Seker H, Bouridane A. Unsupervised selection of RV144 HIV vaccine-induced antibody features correlated to natural killer cell-mediated cytotoxic reactions Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2016:3072-3075 2016 [PMID: 28268960]

Lassa virus

  1. Akkina R, Ellerbrok H, Hall W, Hasegawa H, Kawaguchi Y, Kleanthous H, McSweegan E, Mercer N, Romanowski V, Sawa H, Vahlne A. 2016 International meeting of the Global Virus Network Antiviral research 142:21-29 2017 [PMID: 28315708]

Marburg virus

  1. Hinkula J, Devignot S, Åkerström S, Karlberg H, Wattrang E, Bereczky S, Mousavi-Jazi M, Risinger C, Lindegren G, Vernersson C, Paweska J, Jansen van Vuren P, Blixt O, Brun A, Weber F, Mirazimi A. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice Journal of virology 2017 [PMID: 28250124]

Mycobacterium tuberculosis (tuberculosis)

  1. Jeiranikhameneh M, Razavi MR, Irani S, Siadat SD, Oloomi M. Designing novel construction for cell surface display of protein E on Escherichia coli using non-classical pathway based on Lpp-OmpA AMB Express 7(1):53 2017 [PMID: 28247289]
  2. Shaikh N, Gupte A, Dharmshale S, Pokkali S, Thakar M, Upadhye VJ, Ordonez AA, Kinikar A, Gupte N, Mave V, Kagal A, Gupta A, Lalvani A, Paranjpe R, Bharadwaj R, Jain SK. Novel interferon-gamma assays for diagnosing tuberculosis in young children in India The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 21(4):412-419 2017 [PMID: 28284256]
  3. Brennan MJ. The enigmatic PE/PPE Multi-gene Family of Mycobacteria and TB Vaccination Infection and immunity 2017 [PMID: 28348055]
  4. Thøstesen LM, Stensballe LG, Pihl GT, Kjærgaard J, Birk NM, Nissen TN, Jensen AK, Aaby P, Olesen AW, Jeppesen DL, Benn CS, Kofoed PE. Neonatal BCG-vaccination has no effect on recurrent wheeze in the first year of life. A randomized clinical trial The Journal of allergy and clinical immunology 2017 [PMID: 28347733]
  5. King HC, Khera-Butler T, James P, Oakley BB, Erenso G, Aseffa A, Knight R, Wellington EM, Courtenay O. Environmental reservoirs of pathogenic mycobacteria across the Ethiopian biogeographical landscape PloS one 12(3):e0173811 2017 [PMID: 28333945]
  6. Goulart C, Rodriguez D, Kanno AI, Lu YJ, Malley R, Leite LC. Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy Vaccine 35(13):1683-1691 2017 [PMID: 28242071]
  7. Hu Z, Wong KW, Zhao HM, Wen HL, Ji P, Ma H, Wu K, Lu SH, Li F, Li ZM, Shu T, Xu JQ, Lowrie DB, Fan XY. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice Molecular therapy : the journal of the American Society of Gene Therapy 2017 [PMID: 28342639]
  8. Boucher A, Herrmann JL, Morand P, Buzelé R, Crabol Y, Stahl JP, Mailles A. Epidemiology of infectious encephalitis causes in 2016 Medecine et maladies infectieuses 2017 [PMID: 28341533]
  9. Castelli F, Sulis G. Migration and infectious diseases Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2017 [PMID: 28336382]
  10. Luo M, Samandi LZ, Wang Z, Chen ZJ, Gao J. Synthetic nanovaccines for immunotherapy Journal of controlled release : official journal of the Controlled Release Society 2017 [PMID: 28336379]
  11. Pereira VB, da Cunha VP, Preisser TM, Souza BM, Zurita Turk M, De Castro CP, Azevedo MS, Miyoshi A. Lactococcus lactis carrying a DNA vaccine coding for the ESAT-6 antigen increases IL-17 cytokine secretion and boosts the BCG vaccine immune response Journal of applied microbiology 2017 [PMID: 28314076]
  12. Arlehamn CS, Copin R, Leary S, Mack SJ, Phillips E, Mallal S, Sette A, Blatner G, Siefers H, Ernst JD. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya Human immunology 2017 [PMID: 28315719]
  13. Lau A, Singh V, Soualhine H, Hmama Z. Expression of Cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain Vaccine 2017 [PMID: 28318770]
  14. Gröschel MI, Sayes F, Shin SJ, Frigui W, Pawlik A, Orgeur M, Canetti R, Honoré N, Simeone R, van der Werf TS, Bitter W, Cho SN, Majlessi L, Brosch R. Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection Cell reports 18(11):2752-2765 2017 [PMID: 28297677]
  15. Meng L, Tong J, Wang H, Tao C, Wang Q, Niu C, Zhang X, Gao Q. PPE38 Protein of <i>Mycobacterium tuberculosis</i> Inhibits Macrophage MHC Class I Expression and Dampens CD8<sup>+</sup> T Cell Responses Frontiers in cellular and infection microbiology 7:68 2017 [PMID: 28348981]
  16. Mikheecheva NE, Zaychikova MV, Melerzanov AV, Danilenko VN. A nonsynonymous SNP catalog of Mycobacterium tuberculosis virulence genes and its use for detecting new potentially virulent sublineages Genome biology and evolution 2017 [PMID: 28338924]
  17. Bunyasi EW, Schmidt BM, Abdullahi LH, Mulenga H, Tameris M, Luabeya A, Shenje J, Scriba T, Geldenhuys H, Wood R, Hatherill M. Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol BMJ open 7(3):e014609 2017 [PMID: 28283492]
  18. Teeraananchai S, Bunupuradah T, Puthanakit T, Kerr SJ, Ruxrungtham K, Chaivooth S, Bhakeecheep S, Law MG, Chokephaibulkit K. First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand Journal of acquired immune deficiency syndromes (1999) 2017 [PMID: 28291052]
  19. Li P, Wang R, Dong W, Hu L, Zong B, Zhang Y, Wang X, Guo A, Zhang A, Xiang Y, Chen H, Tan C. Comparative Proteomics Analysis of Human Macrophages Infected with Virulent <i>Mycobacterium bovis</i> Frontiers in cellular and infection microbiology 7:65 2017 [PMID: 28337427]
  20. Lee HJ, Lee DG, Choi SM, Park SH, Cho SY, Choi JK, Kim SH, Choi JH, Yoo JH, Cho BS, Eom KS, Lee S, Kim YJ, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Jung JI. The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population PloS one 12(3):e0173250 2017 [PMID: 28278166]
  21. Prados-Rosales R, Carreño L, Cheng T, Blanc C, Weinrick B, Malek A, Lowary TL, Baena A, Joe M, Bai Y, Kalscheuer R, Batista-Gonzalez A, Saavedra NA, Sampedro L, Tomás J, Anguita J, Hung SC, Tripathi A, Xu J, Glatman-Freedman A, Jacobs WR Jr, Chan J, Porcelli SA, Achkar JM, Casadevall A. Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine PLoS pathogens 13(3):e1006250 2017 [PMID: 28278283]
  22. Sharpe SA, White AD, Sibley L, Gleeson F, Hall GA, Basaraba RJ, McIntyre A, Clark SO, Gooch K, Marsh PD, Williams A, Dennis MJ. An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques PloS one 12(3):e0171906 2017 [PMID: 28273087]
  23. Kwon KW, Kim WS, Kim H, Han SJ, Hahn MY, Lee JS, Nam KT, Cho SN, Shin SJ. Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K Scientific reports 7:44151 2017 [PMID: 28272457]
  24. La Torre G, Scalingi S, Garruto V, Siclari M, Chiarini M, Mannocci A. Knowledge, Attitude and Behaviours towards Recommended Vaccinations among Healthcare Workers Healthcare (Basel, Switzerland) 5(1) 2017 [PMID: 28272332]
  25. Fazlollahi MR, Pourpak Z, Hamidieh AA, Movahedi M, Houshmand M, Badalzadeh M, Nourizadeh M, Mahloujirad M, Arshi S, Nabavi AM, Gharagozlou M, Khayatzadeh A, Dabbaghzade A, Atarod L, Zandieh F, Sadeghi Shabestary M, Mesdaghi M, Mohammadzadeh I, Mahdaviani SA, Eslamian MH, Pesaran F, Bahraminia E, Abolnezhadian F, Arij Z, Moin M. Clinical, Laboratory and Molecular Findings of 63 Patients with Severe Combined Immunodeficiency: A Decade´s Experience Journal of investigational allergology & clinical immunology :0 2017 [PMID: 28266921]
  26. Li Z, Bi Y, Xiao H, Sun L, Ren Y, Li Y, Chen C, Cun W. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes Virus research 2017 [PMID: 28279800]
  27. Ahmed M, Jiao H, Domingo-Gonzalez R, Das S, Griffiths KL, Rangel-Moreno J, Nagarajan UM, Khader SA. Rationalized design of a mucosal vaccine protects against <i>Mycobacterium tuberculosis</i> challenge in mice Journal of leukocyte biology 2017 [PMID: 28258153]
  28. Tanner R, O'Shea MK, White AD, Müller J, Harrington-Kandt R, Matsumiya M, Dennis MJ, Parizotto EA, Harris S, Stylianou E, Naranbhai V, Bettencourt P, Drakesmith H, Sharpe S, Fletcher HA, McShane H. The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays Scientific reports 7:43478 2017 [PMID: 28256545]
  29. Ayubi E, Doosti-Irani A, Sanjari Moghaddam A, Khazaei S, Mansori K, Safiri S, Sani M, Mostafavi E. Comparison of QuantiFERON-TB Gold In-Tube (QFT-GIT) and tuberculin skin test (TST) for diagnosis of latent tuberculosis in haemodialysis (HD) patients: a meta-analysis of κ estimates Epidemiology and infection :1-10 2017 [PMID: 28249638]
  30. Giersing BK, Vekemans J, Nava S, Kaslow DC, Moorthy V. Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016 Vaccine 2017 [PMID: 28262332]
  31. Kathamuthu GR, Moideen K, Baskaran D, Banurekha VV, Nair D, Sekar G, Sridhar R, Vidyajayanthi B, Gajendraraj G, Parandhaman DK, Srinivasan A, Babu S. TB lymphadenitis is associated with enhanced baseline and antigen - specific induction of Type 1 and Type 17 cytokines and reduced IL-1β and IL-18 at the site of infection Clinical and vaccine immunology : CVI 2017 [PMID: 28249842]
  32. Acevedo-Mendoza WF, Buitrago Gómez DP, Atehortua-Otero MÁ, Páez MÁ, Jiménez-Rincón M, Lagos-Grisales GJ, Rodríguez-Morales AJ. Influence of socio-economic inequality measured by the Gini coefficient on meningitis incidence caused by Mycobacterium tuberculosis and Haemophilus influenzae in Colombia, 2008-2011 Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 25(1):8-12 2017 [PMID: 28353449]
  33. Sollai S, Ghetti F, Bianchi L, de Martino M, Galli L, Chiappini E. Infectious diseases prevalence, vaccination coverage, and diagnostic challenges in a population of internationally adopted children referred to a Tertiary Care Children's Hospital from 2009 to 2015 Medicine 96(12):e6300 2017 [PMID: 28328809]
  34. Liang Y, Zhang X, Bai X, Xiao L, Wang X, Zhang J, Yang Y, Song J, Wang L, Wu X. Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice BMC immunology 18(1):11 2017 [PMID: 28241799]
  35. Isaacs-Long Y, Myer L, Zar HJ. Trends in admissions, morbidity and outcomes at Red Cross War Memorial Children's Hospital, Cape Town, 2004 - 2013 South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 107(3):219-226 2017 [PMID: 28281427]
  36. Hwanga EH, Kim TH, Park JY, Hong JJ, Kim DH, Ha SJ, Yang SJ, Shin SJ, Park JH. TLR2 contributes to trigger immune response of pleural mesothelial cells against Mycobacterium bovis BCG and M. tuberculosis infection Cytokine 95:80-87 2017 [PMID: 28249177]
  37. Peddireddy V, Doddam SN, Ahmed N. Mycobacterial Dormancy Systems and Host Responses in Tuberculosis Frontiers in immunology 8:84 2017 [PMID: 28261197]
  38. Rijkers G. Cutting the Stone: Health Defined in the Era of Value-based Care Cureus 9(2):e1023 2017 [PMID: 28348941]
  39. Reyes PR, Parlane NA, Wedlock DN, Rehm BH. Corrigendum to "Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines" [Int. J. Med. Microbiol. 306 (2016) 624-632] International journal of medical microbiology : IJMM 307(2):147 2017 [PMID: 28242005]
  40. Baghani AA, Soleimanpour S, Farsiani H, Mosavat A, Yousefi M, Meshkat Z, Rezaee SA, Jamehdar SA, Eydgahi MR, Sadeghian H, Ghazvini K. CFP10: mFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouse Iranian journal of basic medical sciences 20(2):122-130 2017 [PMID: 28293387]
  41. Clark S, Lanni F, Marinova D, Rayner E, Martin C, Williams A. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis The Journal of infectious diseases 2017 [PMID: 28329234]
  42. Nikitushkin VD, Demina GR, Kaprelyants AS. Rpf Proteins Are the Factors of Reactivation of the Dormant Forms of Actinobacteria Biochemistry. Biokhimiia 81(13):1719-1734 2016 [PMID: 28260493]
  43. Farrell D, Jones G, Pirson C, Malone K, Rue-Albrecht K, Chubb AJ, Vordermeier M, Gordon SV. Integrated computational prediction and experimental validation identifies promiscuous T cell epitopes in the proteome of <i>Mycobacterium bovis</i> Microbial genomics 2(8):e000071 2016 [PMID: 28348866]

Nipah virus

  1. Johnston GP, Contreras EM, Dabundo J, Henderson BA, Matz KM, Ortega V, Ramirez A, Park A, Aguilar HC. Cytoplasmic Motifs in the Nipah Virus Fusion Protein Modulate Virus Particle Assembly and Egress Journal of virology 2017 [PMID: 28250132]

Plasmodium falciparum (Malaria)

  1. Ford T, Wenden C, Mbekeani A, Dally L, Cox JH, Morin M, Winstone N, Hill AV, Gilmour J, Ewer KJ. Cryopreservation-related loss of antigen-specific IFNγ producing CD4<sup>+</sup> T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy Vaccine 35(15):1898-1906 2017 [PMID: 28285985]
  2. Soares RR, Antinarelli LM, Abramo C, Macedo GC, Coimbra ES, Scopel KK. What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis? Pathogens and global health :1-9 2017 [PMID: 28353409]
  3. Dara A, Drábek EF, Travassos MA, Moser KA, Delcher AL, Su Q, Hostelley T, Coulibaly D, Daou M, Dembele A, Diarra I, Kone AK, Kouriba B, Laurens MB, Niangaly A, Traore K, Tolo Y, Fraser CM, Thera MA, Djimde AA, Doumbo OK, Plowe CV, Silva JC. New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali Genome medicine 9(1):30 2017 [PMID: 28351419]
  4. Muh F, Han JH, Nyunt MH, Lee SK, Jeon HY, Ha KS, Park WS, Hong SH, Ahmed MA, Na S, Takashima E, Tsuboi T, Han ET. Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180 Malaria journal 16(1):133 2017 [PMID: 28351409]
  5. Simon UK, Enzinger SM, Fink A. "The evil virus cell": Students' knowledge and beliefs about viruses PloS one 12(3):e0174402 2017 [PMID: 28350815]
  6. Ataide R, Ashley EA, Powell R, Chan JA, Malloy MJ, O'Flaherty K, Takashima E, Langer C, Tsuboi T, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Beeson JG, Nosten F, Simpson JA, White NJ, Fowkes FJ. Host immunity to <i>Plasmodium falciparum</i> and the assessment of emerging artemisinin resistance in a multinational cohort Proceedings of the National Academy of Sciences of the United States of America 114(13):3515-3520 2017 [PMID: 28289193]
  7. Luo K, Zavala F, Gordy J, Zhang H, Markham RB. Extended protection capabilities of an immature dendritic-cell targeting malaria sporozoite vaccine Vaccine 2017 [PMID: 28342669]
  8. Rocha MV, Françoso KS, Lima LC, Camargo TM, Machado RL, Costa FT, Rénia L, Nosten F, Russell B, Rodrigues MM, Soares IS. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1<sub>19</sub> Vaccine 2017 [PMID: 28341111]
  9. Castelli F, Sulis G. Migration and infectious diseases Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2017 [PMID: 28336382]
  10. Luo M, Samandi LZ, Wang Z, Chen ZJ, Gao J. Synthetic nanovaccines for immunotherapy Journal of controlled release : official journal of the Controlled Release Society 2017 [PMID: 28336379]
  11. Al-Quraishy S, Dkhil MA, Abdel-Baki AS, Ghanjati F, Erichsen L, Santourlidis S, Wunderlich F, Araúzo-Bravo MJ. Protective vaccination and blood-stage malaria modify DNA methylation of gene promoters in the liver of Balb/c mice Parasitology research 2017 [PMID: 28315013]
  12. Alaganan A, Singh P, Chitnis CE. Molecular mechanisms that mediate invasion and egress of malaria parasites from red blood cells Current opinion in hematology 2017 [PMID: 28306665]
  13. Pupovac A, Good-Jacobson KL. An antigen to remember: regulation of B cell memory in health and disease Current opinion in immunology 45:89-96 2017 [PMID: 28319732]
  14. Nayakwadi Singer M, Heath C, Muinde J, Gildengorin V, Mutuku FM, Vu D, Mukoko D, King CL, Malhotra IJ, King CH, LaBeaud AD. Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood Pediatrics 2017 [PMID: 28302673]
  15. McCarthy KJ, Braganza S, Fiori K, Gbeleou C, Kpakpo V, Lopez A, Schechter J, Singham Goodwin A, Jones HE. Identifying inequities in maternal and child health through risk stratification to inform health systems strengthening in Northern Togo PloS one 12(3):e0173445 2017 [PMID: 28301539]
  16. Vijayan A, Mejías-Pérez E, Espinosa DA, Raman SC, Sorzano CO, Zavala F, Esteban M. A prime/boost PfCS14K<sup>M</sup>/MVA-sPfCS<sup>M</sup> vaccination protocol generates robust CD8<sup>+</sup> T cell and antibody responses to <i>Plasmodium falciparum</i> circumsporozoite protein and protects mice against malaria Clinical and vaccine immunology : CVI 2017 [PMID: 28298290]
  17. Phares TW, May AD, Genito CJ, Hoyt NA, Khan FA, Porter MD, DeBot M, Waters NC, Saudan P, Dutta S. Rhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomes Malaria journal 16(1):115 2017 [PMID: 28288639]
  18. Laurens MB, Kouriba B, Bergmann-Leitner E, Angov E, Coulibaly D, Diarra I, Daou M, Niangaly A, Blackwelder WC, Wu Y, Cohen J, Ballou WR, Vekemans J, Lanar DE, Dutta S, Diggs C, Soisson L, Heppner DG, Doumbo OK, Plowe CV, Thera MA. Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine PloS one 12(3):e0173294 2017 [PMID: 28282396]
  19. Bennett B, Cohen IG, Davies SE, Gostin LO, Hill PS, Mankad A, Phelan AL. Future-proofing global health: Governance of priorities Global public health :1-9 2017 [PMID: 28271746]
  20. Mahmoudi S, Keshavarz H. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan Human vaccines & immunotherapeutics :1-4 2017 [PMID: 28272979]
  21. Roatt BM, Aguiar-Soares RD, Reis LE, Cardoso JM, Mathias FA, de Brito RC, da Silva SM, Gontijo NF, Ferreira SA, Valenzuela JG, Corrêa-Oliveira R, Giunchetti RC, Reis AB. A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden Frontiers in immunology 8:217 2017 [PMID: 28321217]
  22. Seth L, Bingham Ferlez KM, Kaba SA, Musser DM, Emadi S, Matyas GR, Beck Z, Alving CR, Burkhard P, Lanar DE. Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants Vaccine 2017 [PMID: 28274638]
  23. Giersing BK, Vekemans J, Nava S, Kaslow DC, Moorthy V. Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016 Vaccine 2017 [PMID: 28262332]
  24. Sack B, Kappe SH, Sather DN. Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection Expert review of vaccines :1-12 2017 [PMID: 28277097]
  25. Potter RN, Tremaine LA, Gaydos JC. Mortality Surveillance for Infectious Diseases in the U.S. Department of Defense (1998-2013) Military medicine 182(3):e1713-e1718 2017 [PMID: 28290948]
  26. Chung EJ, Jeong YI, Lee MR, Kim YJ, Lee SE, Cho SH, Lee WJ, Park MY, Ju JW. Heat shock proteins 70 and 90 from Clonorchis sinensis induce Th1 response and stimulate antibody production Parasites & vectors 10(1):118 2017 [PMID: 28249599]
  27. Pereira GA, Souza GC, Santos LS, Barata LE, Meneses CC, Krettli AU, Daniel-Ribeiro CT, Alves CN. Synthesis, antimalarial activity in vitro and docking studies of novel neolignan derivatives Chemical biology & drug design 2017 [PMID: 28245094]
  28. Massaquoi MB, Kennedy SB. Ebola virus and malaria parasite positivity: a febrile illness quagmire The Lancet. Infectious diseases 2017 [PMID: 28258816]
  29. Vaughan AM, Kappe SH. Malaria Parasite Liver Infection and Exoerythrocytic Biology Cold Spring Harbor perspectives in medicine 2017 [PMID: 28242785]
  30. Swapna LS, Parkinson J. Genomics of apicomplexan parasites Critical reviews in biochemistry and molecular biology :1-20 2017 [PMID: 28276701]
  31. Kana IH, Adu B, Tiendrebeogo RW, Singh SK, Dodoo D, Theisen M. Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria The Journal of infectious diseases 2017 [PMID: 28329101]
  32. Requena P, Arévalo-Herrera M, Menegon M, Martínez-Espinosa FE, Padilla N, Bôtto-Menezes C, Malheiro A, Hans D, Castellanos ME, Robinson L, Samol P, Kochar S, Kochar SK, Kochar DK, Desai M, Sanz S, Quintó L, Mayor A, Rogerson S, Mueller I, Severini C, Del Portillo HA, Bardají A, Chitnis CC, Menéndez C, Dobaño C. Naturally Acquired Binding-Inhibitory Antibodies to <i>Plasmodium vivax</i> Duffy Binding Protein in Pregnant Women Are Associated with Higher Birth Weight in a Multicenter Study Frontiers in immunology 8:163 2017 [PMID: 28261219]
  33. Minigo G, Flanagan KL, Slattery RM, Plebanski M. Vaccination with Altered Peptide Ligands of a <i>Plasmodium berghei</i> Circumsporozoite Protein CD8 T-Cell Epitope: A Model to Generate T Cells Resistant to Immune Interference by Polymorphic Epitopes Frontiers in immunology 8:115 2017 [PMID: 28261200]
  34. López C, Yepes-Pérez Y, Hincapié-Escobar N, Díaz-Arévalo D, Patarroyo MA. What Is Known about the Immune Response Induced by <i>Plasmodium vivax</i> Malaria Vaccine Candidates? Frontiers in immunology 8:126 2017 [PMID: 28243235]
  35. Rijkers G. Cutting the Stone: Health Defined in the Era of Value-based Care Cureus 9(2):e1023 2017 [PMID: 28348941]
  36. Al-Deen FM, Xiang SD, Ma C, Wilson K, Coppel RL, Selomulya C, Plebanski M. Magnetic Nanovectors for the Development of DNA Blood-Stage Malaria Vaccines Nanomaterials (Basel, Switzerland) 7(2) 2017 [PMID: 28336871]
  37. Sinden RE. Targeting the Parasite to Suppress Malaria Transmission Advances in parasitology 97:147-185 2017 [PMID: 28325370]
  38. Uyar Y, Akşit A, Karaca S, Ceylan ŞS, Yürük M. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes] Mikrobiyoloji bulteni 51(1):41-51 2017 [PMID: 28283009]
  39. Dhawan R, Kumar M, Mohanty AK, Dey G, Advani J, Prasad TS, Kumar A. Mosquito-Borne Diseases and Omics: Salivary Gland Proteome of the Female Aedes aegypti Mosquito Omics : a journal of integrative biology 21(1):45-54 2017 [PMID: 28271980]
  40. Hegge SR, Hickey BW, Mcgrath SM, Stewart VA. Using Hematology Data from Malaria Vaccine Research Trials in Humans and Rhesus Macaques (<i>Macaca mulatta</i>) To Guide Volume Limits for Blood Withdrawal Comparative medicine 66(6):474-479 2016 [PMID: 28304251]

Rickettsia prowazekii (Typhus fever)

  1. Berséus O. Effects on the anti-ABO titers of military blood donors from a predeployment vaccination program The journal of trauma and acute care surgery 2017 [PMID: 28301394]

Salmonella

  1. Porter CK, Sorrell T, Mitra I, Riddle MS. Vaccination of active component US military personnel against Salmonella Typhi Vaccine 35(14):1742-1748 2017 [PMID: 28268075]
  2. Won G, Hajam IA, Lee JH. Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E Scientific reports 7:45139 2017 [PMID: 28332591]
  3. Won G, Lee JH. Potent immune responses induced by a salmonella ghost delivery system that expresses the recombinant stx2eb, fedf, and feda proteins of the escherichia coli-producing f18 and shiga toxin in a murine model and evaluation of its protective effect as a porcine vaccine candidate The Veterinary quarterly :1-27 2017 [PMID: 28317440]
  4. Diard M, Bakkeren E, Cornuault JK, Moor K, Hausmann A, Sellin ME, Loverdo C, Aertsen A, Ackermann M, De Paepe M, Slack E, Hardt WD. Inflammation boosts bacteriophage transfer between <i>Salmonella</i> spp Science (New York, N.Y.) 355(6330):1211-1215 2017 [PMID: 28302859]
  5. Alima Yanda AN, Nansseu JR, Mbassi Awa HD, Tatah SA, Seungue J, Eposse C, Koki PO. Burden and spectrum of bacterial infections among sickle cell disease children living in Cameroon BMC infectious diseases 17(1):211 2017 [PMID: 28298206]
  6. de la Cruz ML, Conrado I, Nault A, Perez A, Dominguez L, Alvarez J. Vaccination as a control strategy against Salmonella infection in pigs: A systematic review and meta-analysis of the literature Research in veterinary science 114:86-94 2017 [PMID: 28340428]
  7. Greenhow TL, Hung YY, Herz A. Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines Pediatrics 2017 [PMID: 28283611]
  8. Pérez-Toledo M, Valero-Pacheco N, Pastelin-Palacios R, Gil-Cruz C, Perez-Shibayama C, Moreno-Eutimio MA, Becker I, Pérez-Tapia SM, Arriaga-Pizano L, Cunningham AF, Isibasi A, Bonifaz LC, López-Macías C. <i>Salmonella</i> Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens Frontiers in immunology 8:230 2017 [PMID: 28337196]
  9. Jiao Y, Guo R, Tang P, Kang X, Yin J, Wu K, Geng S, Li Q, Sun J, Xu X, Zhou X, Gan J, Jiao X, Liu X, Pan Z. Signature-tagged mutagenesis screening revealed a novel smooth-to-rough transition determinant of Salmonella enterica serovar Enteritidis BMC microbiology 17(1):48 2017 [PMID: 28253852]
  10. Roto SM, Park SH, Lee SI, Kaldhone P, Pavlidis HO, Frankenbach SB, McIntyre DR, Striplin K, Brammer L, Ricke SC. Effects of feeding Original XPC™ to broilers with a live coccidiosis-vaccine under industry conditions: Part 1. Growth performance and Salmonella inhibition Poultry science 2017 [PMID: 28340000]
  11. Hiriart Y, Rossi AH, Biedma ME, Errea AJ, Moreno G, Cayet D, Rinaldi J, Blancá B, Sirard JC, Goldbaum F, Berguer P, Rumbo M. Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella Protein science : a publication of the Protein Society 2017 [PMID: 28257593]
  12. Fresnay S, McArthur MA, Magder LS, Darton TC, Jones C, Waddington CS, Blohmke CJ, Angus B, Levine MM, Pollard AJ, Sztein MB. Importance of <i>Salmonella</i> Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model Frontiers in immunology 8:208 2017 [PMID: 28303138]
  13. Park SH, Roto S, Pavlidis H, McIntyre D, Striplin K, Brammer L, Ricke SC. Effects of feeding Original XPC™ to broilers with a live coccidiosis vaccine under industrial conditions: Part 2. Cecal microbiota analysis Poultry science 2017 [PMID: 28339832]
  14. Fiorino F, Rondini S, Micoli F, Lanzilao L, Alfini R, Mancini F, MacLennan CA, Medaglini D. Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against <i>Salmonella</i> Typhimurium and <i>Salmonella</i> Enteritidis Frontiers in immunology 8:168 2017 [PMID: 28289411]
  15. Giannelli C, Cappelletti E, Di Benedetto R, Pippi F, Arcuri M, Di Cioccio V, Martin LB, Saul A, Micoli F. Determination of free polysaccharide in Vi glycoconjugate vaccine against typhoid fever Journal of pharmaceutical and biomedical analysis 139:143-147 2017 [PMID: 28282600]
  16. Risso GS, Carabajal MV, Bruno LA, Ibañez AE, Coria LM, Pasquevich KA, Lee SJ, McSorley SJ, Briones G, Cassataro J. U-Omp19 from <i>Brucella abortus</i> Is a Useful Adjuvant for Vaccine Formulations against <i>Salmonella</i> Infection in Mice Frontiers in immunology 8:171 2017 [PMID: 28261222]

Shigella

  1. Nickerson KP, Chanin RB, Sistrunk JR, Rasko DA, Fink PJ, Barry EM, Nataro JP, Faherty CS. Analysis of <i>Shigella flexneri</i> Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts Infection and immunity 2017 [PMID: 28348056]

Variola major (Smallpox)

  1. Smallman-Raynor MR, Rafferty S, Cliff AD. Variola minor in coalfield areas of England and Wales, 1921-34: Geographical determinants of a national smallpox epidemic that spread out of effective control Social science & medicine (1982) 180:160-169 2017 [PMID: 28351006]
  2. Jackson LA, Frey SE, El Sahly HM, Mulligan MJ, Winokur PL, Kotloff KL, Campbell JD, Atmar RL, Graham I, Anderson EJ, Anderson EL, Patel SM, Fields C, Keitel W, Rouphael N, Hill H, Goll JB. Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial Vaccine 35(13):1675-1682 2017 [PMID: 28256358]
  3. Realegeno S, Puschnik AS, Kumar A, Goldsmith C, Burgado J, Sambhara S, Olson VA, Carroll D, Damon I, Hirata T, Kinoshita T, Carette JE, Satheshkumar PS. Monkeypox virus host factor screen in haploid cells identifies essential role of GARP complex in extracellular virus formation Journal of virology 2017 [PMID: 28331092]
  4. Springer YP, Hsu CH, Werle ZR, Olson LE, Cooper MP, Castrodale LJ, Fowler N, McCollum AM, Goldsmith CS, Emerson GL, Wilkins K, Doty JB, Burgado J, Gao J, Patel N, Mauldin MR, Reynolds MG, Satheshkumar PS, Davidson W, Li Y, McLaughlin JB. Novel Orthopoxvirus infection in an Alaska resident Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 [PMID: 28329402]
  5. Dornbusch HJ, Hadjipanayis A, Del Torso S, Mercier JC, Wyder C, Schrier L, Ross-Russell R, Stiris T, Ludvigsson JF. We strongly support childhood immunisation-statement from the European Academy of Paediatrics (EAP) European journal of pediatrics 2017 [PMID: 28283786]
  6. Rijkers G. Cutting the Stone: Health Defined in the Era of Value-based Care Cureus 9(2):e1023 2017 [PMID: 28348941]
  7. Zajonc DM. Antibody Recognition of Immunodominant Vaccinia Virus Envelope Proteins Sub-cellular biochemistry 83:103-126 2017 [PMID: 28271474]

Vibrio cholerae

  1. Woodbrey AK, Onyango EO, Pellegrini M, Kovacikova G, Taylor RK, Gribble GW, Kull FJ. A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT Scientific reports 7:45011 2017 [PMID: 28332578]
  2. Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J. Cholera Lancet (London, England) 2017 [PMID: 28302312]
  3. Fasihi-Ramandi M, Ghobadi-Ghadikolaee H, Ahmadi-Renani S, Taheri RA, Ahmadi K. Vibrio cholerae lipopolysaccharide loaded chitosan nanoparticle could save life by induction of specific immunoglobulin isotype Artificial cells, nanomedicine, and biotechnology :1-6 2017 [PMID: 28278575]

Yersinia pestis (Plague)

  1. Dhama K, Kumar N, Saminathan M, Tiwari R, Karthik K, Kumar MA, Palanivelu M, Shabbir MZ, Malik YS, Singh RK. Duck virus enteritis (duck plague) - a comprehensive update The Veterinary quarterly 37(1):57-80 2017 [PMID: 28320263]
  2. McFarland LV. Primary Prevention of Clostridium difficile infections - how difficult can it be? Expert review of gastroenterology & hepatology 2017 [PMID: 28347160]
  3. Aloni-Grinstein R, Schuster O, Yitzhaki S, Aftalion M, Maoz S, Steinberger-Levy I, Ber R. Isolation of <i>Francisella tularensis</i> and <i>Yersinia pestis</i> from Blood Cultures by Plasma Purification and Immunomagnetic Separation Accelerates Antibiotic Susceptibility Determination Frontiers in microbiology 8:312 2017 [PMID: 28293231]
  4. Balakhonov SV, Vityazeva SA, Dubrovina VI, Starovoitova TP, Mukhturgin GB, Ivanova TA, Korytov KM, Kolesnikov SI. Immunogenesis in White Mice Infected with Yersinia pestis with Different Plasmid Composition Bulletin of experimental biology and medicine 162(4):470-473 2017 [PMID: 28243913]

Click HERE to see the publications in the last month.